Global spending on healthcare medicines is expected to reach $ 1.3Tn by end of year 2018.1 While many of these medicines may be developed in the traditional dosage forms, companies are increasingly developing more and more drug delivery devices, in order to deliver patient convenience, more effective routes of administration through targeted therapies, and value to the global payors.
A Nelson & Co Ltd. who manufacture natural healthcare remedies, have experienced an increase in production demands, therefore a solution was required for an automatic process for precise weighing and the collating of production data.
Quality control of Clairol Nice 'n Easy hair colorant kits, packed in cartons at Procter & Gamble's Seaton Delaval site near Newcastle, has been automated with a new checkweigher, custom built by OCS to meet P&G's specific needs.
At the end of a production line the question occurs again and again: "Is everything in the package that belongs there?" The answer is given by the modular construction of the TQCC.
Manufacturers who produce very small objects such as tablets need a dependable and precise quality instrument.
It is important that medications be taken as prescribed by a doctor. Otherwise, there is a possibility that undesirable side effects may occur.
The drug-device combination product market is growing at a rapid pace. By 2019 it is expected that the global market for drug device combination products will reach $115.1 billion. This is nearly double its worth from $66 billion back in 2012. This burgeoning market will likely bring in a flood of product submission applications to the FDA at a time when resources are already strained.